Clinical studies recruiting near Nahariya

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Galilee Medical Center ( Site 1507) · Merck Sharp & Dohme LLC · NCT06136559 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Galilee Medical Center · Regeneron Pharmaceuticals · NCT06091865 Comparison of Sonographic and MRI Weight Estimation in Fetuses with Suspected Macrosomia
NA · Galilee medical center · Western Galilee Hospital-Nahariya · NCT06898892 Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prop
NA · Galilee Medical center · Western Galilee Hospital-Nahariya · NCT06849037 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · Galilee Medical Center, ZIV Medical Center · Ipsen · NCT06016842 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Investigational Site Number : 3760005 · Sanofi · NCT07184931 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Local Subcutaneous Gentamicin for Prevention of Surgical Site Infection After Elective Cesarean Section
NA · Western Galilee Hospital-Nahariya · Western Galilee Hospital-Nahariya · NCT07311395 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 1202 · Anthos Therapeutics, Inc. · NCT05712200 A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, a
Phase 3 · Health Corporation of Galilee Medical Center · Bayer · NCT05196035 A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' D
Phase 2 · Site Number - 4209 · Immunovant Sciences GmbH · NCT07018323 I.V Papavrine for Labor Induction in Term PROM
Phase 4 · Galilee Medical Center · Western Galilee Hospital-Nahariya · NCT07517796 Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
Phase N/A · Galilee Medical Center · Western Galilee Hospital-Nahariya · NCT06821919 Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With En
Phase 3 · Galilee Medical Center · Genmab · NCT07166094 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 3 · Galilee Medical Center · Janssen Research & Development, LLC · NCT07577856 Low Dose Antenatal Corticosteroids for Late Preterm Delivery
NA · Galilee Medical Center · Rambam Health Care Campus · NCT05698966 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652 A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Len
Phase 3 · Galilee Medical Center · Regeneron Pharmaceuticals · NCT06149286 A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · Research Site · AstraZeneca · NCT05774951 AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Can
Phase 3 · Research Site · AstraZeneca · NCT07218809 A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Pr
Phase 2 · Galilee Medical Center · Mirum Pharmaceuticals, Inc. · NCT05050136 Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Phase 3 · Galilee Medical Center · Takeda · NCT07286058 A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Phase 2 · Site 442 · Spyre Therapeutics, Inc. · NCT07012395 A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06215716 AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Phase N/A · Galiee Medical Center · Cordio Medical · NCT06378632 A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor
Phase 3 · Health Corporation of Galilee Medical Center · Bayer · NCT05457283 Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Phase N/A · Galilee Medical Center · Manuel Monreal · NCT02832245

Look up another city

Look up another condition